Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a progressive disease. Despite starting with single oral antidiabetes drug (OAD) therapy and then adding OAD(s), most patients eventually require insulin therapy to achieve and maintain glycemic control. The timely initiation of insulin therapy could he...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Philip A., Zhou, Steve, Gill, Jasvinder, Wei, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397988/
https://www.ncbi.nlm.nih.gov/pubmed/26679966
http://dx.doi.org/10.18553/jmcp.2015.21.12.1172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397988/
https://www.ncbi.nlm.nih.gov/pubmed/26679966
http://dx.doi.org/10.18553/jmcp.2015.21.12.1172

Ejemplares similares